Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a deployment of an updated page version.SummaryDifference0.0%

- Check11 days agoChange DetectedUPMC Hillman Cancer Center was added as a participating location and University of Pittsburgh Cancer Institute (UPCI) was removed from the list of participating sites.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays a new site revision label: Revision: v3.6.4, replacing the previous version tag. This indicates a minor site update without impacting study data or navigation.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a new release/build of the study details page.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer release of the page. This likely reflects minor fixes or tweaks to the page layout or metadata rather than substantive changes to study details.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page adds new sections for participant guidance (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice ('No longer looking for participants'), and updates the page revision to v3.6.0. It also adjusts the heading formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and removes the older 'Revision: v3.5.5'.SummaryDifference0.3%

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.